Prosecution Insights
Prosecution Insights
58 pending office actions • 29 clients • 56 examiners • 36 art units • 0 of 58 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 25 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 25 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 9 (16%) |
| §103 only | 15 (26%) |
| §102 only | 2 (3%) |
| §112 only | 6 (10%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 6 (10%) |
| Multi-statute (no §101) | 19 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 2 | 72.6% | +75.6% |
| VIVLEMORE, TRACY ANN | 2 | 73.0% | +6.7% |
| TRAN, ERIC | 1 | 69.8% | +24.0% |
| QUAIM, LAMIA | 1 | 74.3% | +17.2% |
| WALKER, CHRISTOPHER RICHARD | 1 | 71.9% | +18.0% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +40.1% |
| ANDERSON, JAMES D | 1 | 55.1% | +19.3% |
| OH, TAYLOR V | 1 | 81.2% | +15.4% |
| PACKARD, BENJAMIN J | 1 | 66.5% | +15.6% |
| JACKSON, SHAWQUIA | 1 | 77.9% | -3.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18898755 | CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS | OH, TAYLOR V | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18352677 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | SPAINE, ROBERT FRANKLIN | 441d overdue |
| 18696645 | AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL | AWORUNSE, OLUWABUSAYO ADEBANJO | 146d overdue |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | ANDERSON, JAMES D | 44d overdue |
| 18257639 | AMANITA MUSCARIA COMPOUNDS | HOFFMAN, SUSAN COE | 32d overdue |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | LEE, CHIHYI NMN | 26d overdue |
| 18257766 | PROCESS FOR PRODUCING A THERMOPLASTIC POLYMER-CONTAINING FIBER-REINFORCED COMPOSITE MATERIAL | DONAHUE, OLGA LUCIA | 23d overdue |
| 18299857 | STATIC MAGNETIC FIELD GENERATOR FOR TREATMENT OF CANCER | LANDEEN, BROGAN RANE | 2d overdue |
| 17904419 | DRG-MDM2-2 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR | VALLE, ERNESTO | 19d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | ANDERSON, JAMES D | 44d overdue |
| 18865881 | TRYPTAMINE DERIVATIVES | ABDALHAMEED, MANAHIL MIRGHANI ALI | 35d overdue |
| 18041642 | USE OF A HEPARIN COMPOSITION IN THE TREATMENT OF VIRAL LUNG DISEASES, ACUTE AND/OR CHRONIC LUNG DISEASES BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | SHIAO, YIH-HORNG | 27d |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | — |
| 19252210 | COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING THE POSITION OF A HOLE OR A CRACK IN A DRILL STRING AND COMPUTER-READABLE STORAGE MATERIAL | QUAIM, LAMIA | — |
| 19047044 | SEMq System for Identification, Determination, Characterization, and/or Quantification of Groundwater or Aquifers | WALKER, CHRISTOPHER RICHARD | — |
| 18898755 | CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS | OH, TAYLOR V | — |
| 18815064 | IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY | PACKARD, BENJAMIN J | — |
| Art Unit | Apps |
|---|---|
| 3791 | 4 |
| 1691 | 4 |
| 1629 | 3 |
| 1616 | 2 |
| 1615 | 2 |
| 1766 | 2 |
| 1621 | 2 |
| 1655 | 2 |
| 1763 | 2 |
| 1628 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | TRAN, ERIC | 1629 | §102§112 | Non-Final OA | — | Pending | Dec 09, 2025 |
| 19252210 | COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING THE POSITION OF A HOLE OR A CRACK IN A DRILL STRING AND COMPUTER-READABLE STORAGE MATERIAL | Engineering Simulation And Scientific Software Ltda. | QUAIM, LAMIA | 3676 | §101§112 | Non-Final OA | — | Pending | Jun 27, 2025 |
| 19047044 | SEMq System for Identification, Determination, Characterization, and/or Quantification of Groundwater or Aquifers | G-Strata Spa | WALKER, CHRISTOPHER RICHARD | §103 | Non-Final OA | — | Pending | Feb 06, 2025 | |
| 18865881 | TRYPTAMINE DERIVATIVES | Caamtech, Inc. | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Non-Final OA | 35d overdue | Pending | Nov 14, 2024 |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | Caamtech, Inc. | ANDERSON, JAMES D | 1629 | §102§112 | Non-Final OA | 44d overdue | Pending | Oct 18, 2024 |
| 18898755 | CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS | Caamtech, Inc. | OH, TAYLOR V | §103§112DP | Non-Final OA | — | Pending | Sep 27, 2024 | |
| 18815064 | IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY | William Peranteau | PACKARD, BENJAMIN J | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18781180 | CRYSTALLINE BIS-MIPROCIN FUMARATE | Caamtech, Inc. | JACKSON, SHAWQUIA | §112DP | Non-Final OA | — | Pending | Jul 23, 2024 | |
| 18665039 | PEPTIDE SLOW-RELEASE FORMULATIONS | Camurus AB | CRAIGO, WILLIAM A | 1615 | §112Other | Non-Final OA | 9d overdue | Pending | May 15, 2024 |
| 18696645 | AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL | Tecsoil Automacao E Sistemas S.A | AWORUNSE, OLUWABUSAYO ADEBANJO | 3662 | §101§103§112 | Non-Final OA | 146d overdue | Pending | Mar 28, 2024 |
| 18615593 | CURABLE SILOXANE-MODIFIED RESIN COMPOSITIONS WITH SILICONE-OIL ADDITIVES AND USE THEREOF | Ndsu Research Foundation | HESTER, HOLLEY GRACE | 1766 | §102§103§112 | Non-Final OA | — | Pending | Mar 25, 2024 |
| 18688672 | METHOD FOR PRODUCING PRESERVED COLLAGENOUS CONNECTIVE TISSUE, COLLAGENOUS CONNECTIVE TISSUE, USES THEREOF AND KIT FOR IMPLANT IN TISSUES | Labcor Laboratorios Ltda | PENNINGTON, KATIE LEIGH | 1634 | §103§112DP | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18683842 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | WEDDINGTON, KEVIN E | 1629 | §112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18407432 | WIRELESS HEART TELEMETRY ELECTRODES AND PATIENT MONITORING SYSTEM | Jmad Creations, LLC | WINAKUR, ERIC FRANK | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18572257 | PROTEIN BIOMARKER INDICATORS OF NEUROLOGICAL INJURY AND/OR DISEASE AND METHODS OF USE THEREOF | Brainbox Solutions, Inc. | VOLKOV, ALEXANDER ALEXANDROVIC | §101§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 | |
| 18569507 | HIGH CLARITY AND DUCTILE MOLDING COMPOSITION COMPRISING A SMMA COPOLYMER AND A SBC-BLOCK COPOLYMER | Ineos Styrolution Group GmbH | FOSS, DAVID ROGER | DP | Non-Final OA | — | Pending | Dec 12, 2023 | |
| 18563898 | HALLUCINOGEN-FATTY ACID COMBINATION | Mindset Pharma Inc. | RONEY, CELESTE A | 1612 | §112 | Non-Final OA | — | Pending | Nov 23, 2023 |
| 18562183 | MICROORGANISM STRAIN AND METHOD FOR ANTIBIOTIC-FREE PLASMID-BASED FERMENTATION | Gen-H Genrtic Engineering Heidelberg GmbH | DICKENS, AMELIA NICOLE | 1645 | §102§103§112 | Final Rejection | — | Pending | Nov 17, 2023 |
| 18553868 | PSEUDO SOLID PHASE PROTECTING GROUP AND METHODS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES AND OLIGONUCLEOTIDE CONJUGATES | BACHEM AG | CREWS, JARET JAMES | 1691 | §103§112 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18469884 | CATALYST FORMULATION FOR DIRECT CONVERSION OF MICROALGAE IN GROWTH MEDIUM TO BIOFUELS | Socar Turkey Arastirma Gelistirme Ve Inovasyon A.S. | MCDONOUGH, JAMES E | 1734 | §103 | Final Rejection | 1d overdue | Pending | Sep 19, 2023 |
| 18550793 | IMPROVED OLIGONUCLEOTIDE SYNTHESIS | BACHEM AG | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18279290 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | AULAKH, CHARANJIT | 1621 | §112 | Final Rejection | 5d | Pending | Aug 29, 2023 |
| 18546014 | COATING MATERIAL, COATING FILM, LAYERED PRODUCT, AND FLEXIBLE FLAT CABLE | Riken Technos Corporation | HON, SOW FUN | 1782 | §112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18352677 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | Caamtech, Inc. | SPAINE, ROBERT FRANKLIN | 1655 | §103§112 | Final Rejection | 441d overdue | Pending | Jul 14, 2023 |
| 18348866 | CURABLE COATING COMPOSITIONS HAVING SUPERHYDROPHOBIC, ANTI-ICING, AND ANTI-CORROSION PROPERTIES | Ndsu Research Foundation | MILLER, BETHANY MACKENZIE | 1787 | §103§112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18257639 | AMANITA MUSCARIA COMPOUNDS | Caamtech, Inc. | HOFFMAN, SUSAN COE | 1655 | §101§102§112 | Non-Final OA | 32d overdue | Pending | Jun 15, 2023 |
| 18257766 | PROCESS FOR PRODUCING A THERMOPLASTIC POLYMER-CONTAINING FIBER-REINFORCED COMPOSITE MATERIAL | Ineos Styrolution Group GmbH | DONAHUE, OLGA LUCIA | 1763 | §103§112 | Non-Final OA | 23d overdue | Pending | Jun 15, 2023 |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Mindset Pharma Inc. | LEE, CHIHYI NMN | 1628 | §103§112 | Final Rejection | 26d overdue | Pending | Jun 05, 2023 |
| 18254632 | UV RESISTANT SMMA COPOLYMERS WITH LOW HAZE AND HIGH CLARITY | Ineos Styrolution Group GmbH | USELDING, JOHN E | 1763 | §103§112Other | Non-Final OA | — | Pending | May 26, 2023 |
| 18310945 | PREVENTING DECOMPOSITION IN SODIUM CYANIDE COMPOSITIONS | Cyanco Corporation | NGUYEN, CAM N | 1736 | §102§112 | Non-Final OA | — | Pending | May 02, 2023 |
| 18249848 | NANOFILTRATION ASSISTED METHODS OF CHEMICAL SYNTHESIS | BACHEM AG | REYNOLDS, FRED H | 1658 | §102§103Other | Non-Final OA | 43d | Pending | Apr 20, 2023 |
| 18299857 | STATIC MAGNETIC FIELD GENERATOR FOR TREATMENT OF CANCER | BRAIN & BEYONDS CO., LTD. | LANDEEN, BROGAN RANE | 3791 | §101§103 | Final Rejection | 2d overdue | Pending | Apr 13, 2023 |
| 18245053 | USE OF ACTIVE SUBSTANCES WITH ANTIVIRAL, ANTI MALARIAL, AND/OR MUCOLYTIC PROPERTIES IN THE TREATMENT OF VIRAL LUNG DISEASES INCLUDING COVID-19 BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Istanbul Universitesi Rektolugu | HAGHIGHATIAN, MINA | 1616 | §102§103§112 | Final Rejection | — | Pending | Mar 13, 2023 |
| 18178041 | COMPOSITION FOR IMPROVING THE APPEARANCE OF AGEING SKIN | Merz Pharma GmbH & Co. Kgaa | PURDY, KYLE A | 1611 | §103 | Non-Final OA | — | Pending | Mar 03, 2023 |
| 18041642 | USE OF A HEPARIN COMPOSITION IN THE TREATMENT OF VIRAL LUNG DISEASES, ACUTE AND/OR CHRONIC LUNG DISEASES BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Istanbul Universitesi Rektorlugu | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | 27d | Pending | Feb 14, 2023 |
| 18161828 | MIXTURES AND FORMULATIONS | Camurus AB | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103DP | Non-Final OA | — | Pending | Jan 30, 2023 |
| 17923314 | HYDROGEL IRRADIATION | Ascendis Pharma A/S | MEJIAS, SAMANTHA LEE | 1618 | §103Other | Final Rejection | 38d overdue | Pending | Nov 04, 2022 |
| 18051678 | BIO-BASED FURANIC DI(METH)ACRYLATES AS REACTIVE DILUENTS FOR UV CURABLE COATINGS | Ndsu Research Foundation | EGWIM, KELECHI CHIDI | 1762 | §102 | Final Rejection | 4d overdue | Pending | Nov 01, 2022 |
| 17997600 | THERMOPLASTIC POLYMER COMPOSITION WITH REDUCED MIGRATION OF STABILISERS | Ineos Styrolution Group GmbH | RODD, CHRISTOPHER M | 1766 | §103 | Non-Final OA | — | Pending | Oct 31, 2022 |
| 17916199 | NANOPARTICLE PROVISION MEDIUM FOR THERMOTHERAPY AND THERMOTHERAPY SYSTEM USING SAME | BRAIN & BEYONDS CO., LTD. | COX, THADDEUS B | 3791 | §102§103§112 | Final Rejection | 23d | Pending | Sep 30, 2022 |
| 17904419 | DRG-MDM2-2 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR | Istanbul Teknik Universitesi | VALLE, ERNESTO | 1623 | §102§103 | Non-Final OA | 19d | Pending | Aug 17, 2022 |
| 17759420 | INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATION | Merz Pharma GmbH & Co. Kgaa | NGUYEN, NGOC-ANH THI | 1615 | §103 | Non-Final OA | — | Pending | Jul 25, 2022 |
| 17790589 | CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTS | Ascendis Pharma A/S | PIHONAK, SARAH | 1627 | §112 | Non-Final OA | — | Pending | Jul 01, 2022 |
| 17776092 | APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS | BACHEM AG | BUNKER, AMY M | 1684 | §103 | Non-Final OA | — | Pending | May 11, 2022 |
| 17773241 | B-CELL ANTIBODY RECEPTOR AND USE THEREOF | Medinet Co., Ltd. | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Final Rejection | — | Pending | Apr 29, 2022 |
| 17768045 | WEATHERING-RESISTANT STYRENE COPOLYMER MOLDING COMPOSITIONS WITH REDUCED MOLD DEPOSIT FORMATION FOR HIGH GLOSS APPLICATIONS | Ineos Styrolution Group GmbH | WOODWARD, ANA LUCRECIA | 1765 | §103DP | Final Rejection | 29d overdue | Pending | Apr 11, 2022 |
| 17767299 | THERMOPLASTIC RECYCLING MOLDING COMPOSITION BASED ON RECYCLED ACRYLONITRILE-BUTADIENE-STYRENE COPOLYMERS AND PROCESS FOR ITS PREPARATION | Ineos Styrolution Group GmbH | ILLING, CAITLIN NORINE | 1767 | §103 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17627988 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | Caamtech, Inc. | NOTTINGHAM, KYLE GREGORY | 1621 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 18, 2022 |
| 17627488 | IMMOBILIZED ENZYME COMPOSITIONS FOR THE PRODUCTION OF HEXOSES | BONUMOSE, INC. | SPANGLER, JOSEPH RANKIN | 1656 | §103Other | Final Rejection | 8d overdue | Pending | Jan 14, 2022 |
| 17620855 | IBOGAINE FORMULATIONS | Caamtech, Inc. | PECKHAM, RICHARD GRANT | 1627 | §101§103 | Final Rejection | — | Pending | Dec 20, 2021 |
| 17612326 | BODY TEMPERATURE DIAGNOSTICS | Vivosensmedical GmbH | TU, AURELIE H | 3791 | §101§102§103§112 | Non-Final OA | 29d | Pending | Nov 18, 2021 |
| 17495069 | ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | Caamtech, Inc. | CORNET, JEAN P | 1628 | §103§112Other | Non-Final OA | 54d | Pending | Oct 06, 2021 |
| 17387883 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Mindset Pharma Inc. | MCDOWELL, BRIAN E | 1624 | §102 | Final Rejection | 89d overdue | Pending | Jul 28, 2021 |
| 17312249 | A METHOD TO DETERMINE AGENTS FOR PERSONALIZED USE | Henry Johannes Greten | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112 | Non-Final OA | — | Pending | Jun 09, 2021 |
| 17186762 | SYSTEMS AND METHODS FOR CARBON DIOXIDE ENHANCED DELIVERY OF TOPICAL SUBSTANCES | Cryoconcepts LP | SMITH, PETER DANIEL | 3781 | §103 | Final Rejection | 46d overdue | Pending | Feb 26, 2021 |
| 16968146 | IMPROVED ALPHA-BETA T PROCESSED CELL PRODUCTION METHOD | Medinet Co., Ltd. | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | — | Pending | Aug 06, 2020 |
| 16936769 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | Caamtech LLC | LEE, ANDREW P | 1691 | §103 | Final Rejection | 42d overdue | Pending | Jul 23, 2020 |
| 16456773 | RNA VIRUSES EXPRESSING IL-12 FOR IMMUNOVIROTHERAPY | Ruprecht-Karls Universitaet | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | 98d overdue | Pending | Jun 28, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial